Clinical trial
Observational Retrospective CoHort Study on Practical ExperienceS of Treatment With Foslevodopa/foScaRbidopa in Advanced Parkinson's Disease
NCT06937034 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observational Retrospective CoHort Study on Practical ExperienceS of Treatment With Foslevodopa/foScaRbidopa in Advanced Parkinson's Disease
- Lead sponsor
- AbbVie
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- April 14, 2025
- Completion date
- December 31, 2025
- Enrollment
- 2,000 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
parkinson's disease